Nasal spray delivers antipsychotic drugs straight to the brain, cutting required dose by up to 75 per cent and reducing adverse side effects
The leap in efficiency means patients with schizophrenia, bipolar disorder and other conditions could see their doses of powerful antipsychotic medications cut by as much as three quarters.